Activated CD4+and CD8+T Cell Proportions in Multiple Sclerosis Patients

被引:15
作者
Arneth, Borros [1 ,2 ]
机构
[1] Justus Liebig Univ Giessen, Univ Hosp Giessen & Marburg, Inst Lab Med & Pathobiochem, Mol Diagnost, Feulgenstr 12, D-35392 Giessen, Germany
[2] Tech Univ Dresden, Inst Clin Chem & Lab Med, Fetscherstr 74, D-01307 Dresden, Germany
关键词
multiple sclerosis; T lymphocytes; CD4+T helper cells; CD8+cytotoxic T cells; CD8(+) T-CELLS; CEREBROSPINAL-FLUID; TREATED PATIENTS; FINGOLIMOD; KINETICS; RATIO;
D O I
10.1007/s10753-016-0441-0
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The goal of this study was to trace the course of multiple sclerosis (MS) by evaluating the lymphocyte subpopulation counts and the levels of CD4+ and CD8+ T cell activation using flow cytometry. Samples obtained from healthy subjects (N = 40) and patients with MS (N = 290) were analyzed. Lymphocytes were labeled for the surface markers CD4+, CD8+, CD3+, CD16+, CD19+, CD45+, and CD53+ and the activation marker HLA-DR+. Cell counts were then determined using flow cytometry. A high degree of inter-individual variability was observed in the counts of all lymphocyte subtypes in the MS group. A significantly lower proportion of CD3+ T cells (69 +/- 14 % in healthy subjects and 60 +/- 17 % as a percent of total lymphocytes in MS patients), CD4+ T cells (41 +/- 11 and 28 +/- 18 %, respectively), and a significantly higher proportion of NK T cells (12 +/- 5 and 25 +/- 21 %, respectively) were observed in patients with MS than in healthy subjects. These differences led to a lowered CD4+/CD8+ T cell ratio. Furthermore, a significantly lower proportion of activated CD4+ T cells (HLA-DR+ CD4+; from 48 +/- 10 to 38 +/- 15 % as a percent of CD4+ cells) was observed in patients with MS than in healthy subjects. The high level of inter-individual variability in lymphocyte cell counts and the counts of activated T cells suggest that MS is a complex and heterogeneous disease.
引用
收藏
页码:2040 / 2044
页数:5
相关论文
共 17 条
  • [1] Early activation of CD4+and CD8+T lymphocytes by myelin basic protein in subjects with MS
    Arneth, Borros
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2015, 13
  • [2] Newly produced T and B lymphocytes and T-cell receptor repertoire diversity are reduced in peripheral blood of fingolimod-treated multiple sclerosis patients
    Chiarini, M.
    Sottini, A.
    Bertoli, D.
    Serana, F.
    Caimi, L.
    Rasia, S.
    Capra, R.
    Imberti, L.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2015, 21 (06) : 726 - 734
  • [3] Compositional Changes of B and T Cell Subtypes during Fingolimod Treatment in Multiple Sclerosis Patients: A 12-Month Follow-Up Study
    Claes, Nele
    Dhaeze, Tessa
    Fraussen, Judith
    Broux, Bieke
    Van Wijmeersch, Bart
    Stinissen, Piet
    Hupperts, Raymond
    Hellings, Niels
    Somers, Veerle
    [J]. PLOS ONE, 2014, 9 (10):
  • [4] KINETICS OF MATURE T-CELL DEVELOPMENT IN THE THYMUS
    EGERTON, M
    SCOLLAY, R
    SHORTMAN, K
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (07) : 2579 - 2582
  • [5] Modulation of CNS autoimmune responses by CD8+ T cells coincides with their oligoclonal expansion
    Fischer, Henrike J.
    van den Brandt, Jens
    Lingner, Thomas
    Odoardi, Francesca
    Fluegel, Alexander
    Weishaupt, Andreas
    Reichardt, Holger M.
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 2016, 290 : 26 - 32
  • [6] High interindividual variability in the CD4/CD8 T cell ratio and natalizumab concentration levels in the cerebrospinal fluid of patients with multiple sclerosis
    Harrer, A.
    Pilz, G.
    Wipfler, P.
    Oppermann, K.
    Sellner, J.
    Hitzl, W.
    Haschke-Becher, E.
    Afazel, S.
    Rispens, T.
    van der Kleij, D.
    Trinka, E.
    Kraus, J.
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2015, 180 (03) : 383 - 392
  • [7] Basis for fluctuations in lymphocyte counts in fingolimod-treated patients with multiple sclerosis
    Henault, David
    Galleguillos, Lorna
    Moore, Craig
    Johnson, Trina
    Bar-Or, Amit
    Antel, Jack
    [J]. NEUROLOGY, 2013, 81 (20) : 1768 - 1772
  • [8] GATA-3 expression is controlled by TCR signals and regulates CD4/CD8 differentiation
    Hernández-Hoyos, G
    Anderson, MK
    Wang, C
    Rothenberg, EV
    Alberola-Ila, J
    [J]. IMMUNITY, 2003, 19 (01) : 83 - 94
  • [9] EVIDENCE FOR A SINGLE-NICHE MODEL OF POSITIVE SELECTION
    MERKENSCHLAGER, M
    BENOIST, C
    MATHIS, D
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (24) : 11694 - 11698
  • [10] How many thymocytes audition for selection?
    Merkenschlager, M
    Graf, D
    Lovatt, M
    Bommhardt, U
    Zamoyska, R
    Fisher, AG
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (07) : 1149 - 1158